Problem:  Competitive Horses when injured are typically treated with “Rest and Bruit”: Average Recovery times vary between 6 and 24 weeks depending on the injury In Racing Recovery time equals Lost Revenue In Competition Horses Recovery Time equates to Lost Opportunity

Solution: Horse Therapy LLC  Pulsed Electromagnetic Field Therapy (PEMF) Significantly Reduces Recovery Time by 30 – 50 % Simple non-invasive minute Treatment Full Spectrum Frequency Design Small Easy to Use Portable Device Widely accepted Veterinary approved Technology

Introduction to Pulsed ElectroMagnetic Field (PEMF Technology)  Discovered in the 60’s by NASA and MIR Space Missions All Species evolved in Earths Pulsating Magnetic Fields. PEMF fields are as important to earth borne species as are air and water.

Introduction to Pulsed ElectroMagnetic Field (PEMF Technology)  Healthy Cells Resonate/Radiate “Coherent” Frequencies  Diseased or injured Cells do not resonate well and emit frequencies of a chaotic nature*  Full Frequency PEMF fields restore and recharge damaged cells to Coherent Resonance  This significantly reduces Healing Time and Speeds Recovery *(Reerence 1 +2) Mammalian Cells are “Charged” by PMEF fields

Introduction to Pulsed ElectroMagnetic Field (PEMF Technology)  The Clinically Proven Benefits of PEMF Therapy include  Decreased pain  Improved Sleep  Enhances Circulation  Nerve Regeneration  Speeds Wound Healing  Enhances Immunity  Improvement in Bone Density  Oxygen uptake is improved

 PEMF Therapy is widely used in conditioning Race and Competitive Horses around the world.  PEMF therapy regenerates damaged and diseased tissue, repairs torn tendons and fractured bones. Reference (3,4,5)  PEMF therapy improves circulation by opening and dilating the arteries and capillaries. This also reduces edema (swelling). Reference (2)  PEMF therapy increases the cellular level of oxygen absorption. Studies have shown that oxygen partial pressure can be increased by 200%. This reduces pain  PEMF therapy is particularly effective in getting to deep muscle soreness (back, stifle, etc.) because of its deep penetration. There is a boatload of clinical data Supporting the Clinical Safety and Efficacy of PEMF Therapy. Search the Internet

Competition  There are at least 6 Competitive Machines on the market.

The Horse Therapies Difference:  Designed specifically for Equine Applications  Lightweight and Portable One Quarter the size of most machines  Full Spectrum Frequency Machine Specific Frequencies target key locations and organ systems.  Simple to use – backed by a 3 year warranty

Market Strategy: Market Strategy:  Horse Therapies intends to pursue a targeted market entry strategy. Play to our unique product strengths No other machine combines :  Full Frequency  True Portability  Simplicity of use and settings These Markets are “Non-Strategic” to our main competitors. We are Focused on Equine Health

Path to Market  Centers of Excellence Model: Teaching Treatment Stables Trainers can be proctored in PEMF Therapy Establish 10 centers with Direct Sales ○ Three in Europe ○ 7 in the United States Establish national distribution agreements Specialty Sales Force for distributor support

Treatment Testimonials  Demonstrating the healing power of PEMF PEMF Horse Therapy Case Study – Nasak Nasak, a horse with advanced wound infection Once this advanced these types of wounds rarely close

Contact:

References: 1. Shupak NM, Prato FS, Thomas AW. Therapeutic uses of pulsed magnetic field exposure: A review. URSI: The Radio Science Bulletin 2003;307: Peer-Reviewed Scientific Studies on the Effects of Magnetics on Physical Ailments 3. Adams, B. D.; Frykman, G. K.; and Taleisnik, J. Treatment of scaphoid nonunion with casting and pulsed electromagnetic fields: a study continuation. J Hand Surg [Am] Sep; 17 (5): Barker AT, et al. Pulsed magnetic field therapy for tibial non-union. Interim results of a double-blind trial. Lancet May 5;1(8384): Bassett, C. A.; Mitchell, S. N.; and Gaston, S. R. Pulsing electromagnetic field treatment in ununited fractures and failed arthrodeses. JAMA 1982 Feb 5; 247 (5): This potential modality of treatment is not addresses by the rules of the U.S. E.T. or E.F.I.